Search results for "myocardial infarction."

showing 10 items of 1011 documents

Persistence of High Plasma Elastase Level in Young Subjects With Acute Myocardial Infarction

2007

AdultMalemedicine.medical_specialtyMyocardial Infarction030204 cardiovascular system & hematologyPersistence (computer science)03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumans030212 general & internal medicineMyocardial infarctionPancreatic elastasePancreatic Elastasebusiness.industryElastaseHematologyGeneral MedicineMiddle Agedmedicine.diseaseHigh plasmaAcute DiseaseCardiologyFemalebusinessClinical and Applied Thrombosis/Hemostasis
researchProduct

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-co…

2008

Background: Whether nucleoside reverse transcriptase inhibitors increase the risk of myocardial infarction in HIV-infected individuals is unclear. Our aim was to explore whether exposure to such drugs was associated with an excess risk of myocardial infarction in a large, prospective observational cohort of HIV-infected patients. Methods: We used Poisson regression models to quantify the relation between cumulative, recent (currently or within the preceding 6 months), and past use of zidovudine, didanosine, stavudine, lamivudine, and abacavir and development of myocardial infarction in 33 347 patients enrolled in the D:A:D study. We adjusted for cardiovascular risk factors that are unlikely…

AdultMalemedicine.medical_specialtyMyocardial Infarction610 Medicine & healthHIV Infections2700 General MedicinePharmacologyArticle10234 Clinic for Infectious DiseasesZidovudineAbacavirRisk FactorsInternal medicinemedicine80 and overHumansHIV InfectionMyocardial infarctionPoisson DistributionDidanosineAgedAged 80 and overbusiness.industryRisk FactorMedicine (all)StavudineLamivudineGeneral MedicineAbacavir/LamivudineMiddle Agedmedicine.diseaseDideoxynucleosideDideoxynucleosidesReverse Transcriptase InhibitorDidanosineCohortReverse Transcriptase InhibitorsFemalebusinessmedicine.drugHuman
researchProduct

Predictors of cardiovascular magnetic resonance-derived microvascular obstruction on patient admission in STEMI

2010

Early stratification of patients according to the risk for developing microvascular obstruction (MVO) after ST-segment elevation myocardial infarction (STEMI) is desirable. We aimed to identify predictors of cardiovascular magnetic resonance (CMR)-derived MVO from clinical+ECG, laboratory and angiographic parameters available on admission.Characteristics available on admission were documented in 97 STEMI patients referred for primary angioplasty. MVO was determined using contrast-enhanced CMR.MVO was present in 44 patients (45%). The C-statistic for predicting MVO was: clinical+ECG (.832), laboratory (.743), and angiographic parameters (.669). Adding laboratory to clinical+ECG information d…

AdultMalemedicine.medical_specialtyMyocardial InfarctionMagnetic Resonance Imaging CineCoronary Artery DiseaseDelayed presentationPatient AdmissionPredictive Value of TestsCoronary CirculationDiabetes mellitusInternal medicineHumansMedicineProspective Studiescardiovascular diseasesMyocardial infarctionProspective cohort studyAgedKillip classmedicine.diagnostic_testbusiness.industryMicrocirculationMagnetic resonance imagingMiddle Agedmedicine.diseaseSurgeryPredictive value of testsCardiologyFemaleMyocardial infarction diagnosisCardiology and Cardiovascular Medicinebusinesshuman activitiesInternational Journal of Cardiology
researchProduct

Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction

2009

Abstract Introduction The association of the temporal evolution of cardiac necrosis marker release with cardiovascular magnetic resonance-derived microvascular perfusion after ST-elevation myocardial infarction is unknown. Methods We analyzed 163 patients with a first ST-elevation myocardial infarction and a patent infarct-related artery treated with thrombolysis (67%) or primary angioplasty (33%). Using first-pass perfusion CMR, abnormal perfusion was defined as a lack of contrast arrival into the infarct area in > 1 segment. Troponin I, creatine kinase MB and myoglobin were measured upon arrival and at 6, 12, 24, 48 and 96 hours after reperfusion. Results Abnormal perfusion was detected i…

AdultMalemedicine.medical_specialtyMyocardial InfarctionMyocardial Reperfusion InjuryCoronary AngiographyNecrosisReperfusion therapyInternal medicineTroponin ImedicineCreatine Kinase MB FormHumansProspective StudiesMyocardial infarctionAngioplasty Balloon CoronaryAgedmedicine.diagnostic_testbiologyMyoglobinbusiness.industryMyocardiumST elevationMagnetic resonance imagingHematologyMiddle AgedPrognosismedicine.diseaseMagnetic Resonance ImagingTroponinTroponinTreatment Outcomebiology.proteinCardiologyFemaleCreatine kinasebusinessPerfusionBiomarkersThrombosis Research
researchProduct

All-cause and disease-specific mortality among male, former elite athletes: an average 50-year follow-up.

2014

Aim To investigate life expectancy and mortality among former elite athletes and controls. Methods HR analysis of cause-specific deaths sourced from the national death registry for former Finnish male endurance, team and power sports athletes (N=2363) and controls (N=1657). The median follow-up time was 50 years. Results Median life expectancy was higher in the endurance (79.1 years, 95% CI 76.6 to 80.6) and team (78.8, 78.1 to 79.8) sports athletes than in controls (72.9, 71.8 to 74.3). Compared to controls, risk for total mortality adjusted for socioeconomic status and birth cohort was lower in the endurance ((HR 0.70, 95% CI 0.61 to 0.79)) and team (0.80, 0.72 to 0.89) sports athletes, a…

AdultMalemedicine.medical_specialtyMyocardial InfarctionPoison controlPhysical Therapy Sports Therapy and Rehabilitation030204 cardiovascular system & hematology03 medical and health sciencesYoung Adult0302 clinical medicineLife ExpectancyCause of DeathNeoplasmsEpidemiologyInjury preventionmedicineHumansOrthopedics and Sports MedicineYoung adultFinlandAgedAged 80 and overbiologybusiness.industryAthletes030229 sport sciencesGeneral MedicineMiddle Agedmedicine.diseasebiology.organism_classificationSurvival Analysis3. Good healthStrokeChronic traumatic encephalopathyCase-Control StudiesCohortLife expectancyPhysical therapyDementiabusinesshuman activitiesFollow-Up StudiesSportsBritish journal of sports medicine
researchProduct

Changes in plasma lipids and low-density lipoprotein peak particle size during and after acute myocardial infarction

2002

In summary, LDL peak particle size variations occur very early after AMI, and therefore this parameter, which may be considered a genetically determined risk factor, must be measured not before 2 to 3 months after the acute event.

AdultMalemedicine.medical_specialtyMyocardial Infarctionchemistry.chemical_compoundInternal medicineBlood plasmaPlasma lipidsmedicineHumansMyocardial infarctionLow-Density Lipoprotein Acute Myocardial InfarctionRisk factorAgedAged 80 and overbusiness.industryCholesterolCholesterol HDLCholesterol LDLMiddle Agedmedicine.diseaseLipidsCoronary heart diseaseEndocrinologychemistryLow-density lipoproteinCardiologyParticle sizeCardiology and Cardiovascular MedicinebusinessThe American Journal of Cardiology
researchProduct

Behaviour of carbonyl groups in several clinical conditions: Analysis of our survey

2019

Protein carbonylation is a marker of oxidative protein damage, that is likely involved in the pathogenesis of several diseases. The aim of this study was to evaluate the protein carbonyl (PC) groups in different clinical conditions. It included different groups of subjects: 81 trained subjects; 23 subjects with mild essential hypertension; 31 middle-aged subjects with metabolic syndrome (MS); 106 subjects with MS not selected for age (subdivided into two subgroups, with and without diabetes mellitus); 91 obese adults subdivided in two subgroups (BMI 30-35 Kg/m2 and BMI > 35 kg/m2); 48 subjects with obstructive sleep apnea syndrome (OSAS) subdivided in accordance with the apnea/hypopnea i…

AdultMalemedicine.medical_specialtyOxidative stress arterial hypertension metabolic syndrome juvenile myocardial infarction chronic kidney failurePhysiologymedicine.medical_treatment030204 cardiovascular system & hematologyEssential hypertension030218 nuclear medicine & medical imagingProtein Carbonylation03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesPhysiology (medical)Internal medicineDiabetes mellitusmedicineHumansDiseaseMyocardial infarctionDialysisbusiness.industryHematologymedicine.diseaseObstructive sleep apneaFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessOxidation-ReductionHypopneaBiomarkersKidney diseaseClinical Hemorheology and Microcirculation
researchProduct

Evidence of the role of short-term exposure to ozone on ischaemic cerebral and cardiac events: the Dijon Vascular Project (DIVA)

2010

Objectives To confirm the effects of short-term exposure to ozone (O 3 ) on ischaemic heart and cerebrovascular disease. Methods Daily levels of urban O 3 pollution, the incidence of first-ever, recurrent, fatal and non-fatal ischaemic cerebrovascular events (ICVE) and myocardial infarction (MI) were correlated using a case-crossover design. The authors analysed 1574 ICVE and 913 MI that occurred in Dijon, France (150 000 inhabitants) from 2001 to 2007. Sulfur dioxide (SO 2 ), nitrogen dioxide (NO 2 ), carbon monoxide (CO) and particulate matter with an aerodiameter of ≤10 μg/m 3 (PM 10 ) were used to create bi-pollutant models. Using the adjusted OR, the effects of O 3 exposure were calcul…

AdultMalemedicine.medical_specialtyOzoneHypercholesterolemiaMyocardial InfarctionBlood lipidsSubgroup analysisVascular riskBrain Ischemiachemistry.chemical_compoundOzoneRecurrenceInternal medicineEpidemiologymedicineHumansMyocardial infarctionAgedAir PollutantsCross-Over Studiesbusiness.industryIncidence (epidemiology)Environmental ExposureMiddle Agedmedicine.diseaseSurgerychemistryIschemic Attack TransientCase-Control StudiesHypertensionCirculatory systemCardiologyFemaleFranceCardiology and Cardiovascular MedicinebusinessDiabetic AngiopathiesHeart
researchProduct

Defining normality in a European multinational cohort: Critical factors influencing the 99th percentile upper reference limit for high sensitivity ca…

2015

To establish and critically evaluate the 99th percentile upper reference limit (URL) for high-sensitivity cardiac troponin I (hs-cTnI) in a large healthy European cohort using different selection criteria.1368 presumably healthy individuals from 9 countries were evaluated with surrogate biomarkers for diabetes (glycated hemoglobin [HbA1c]48 mmol/mol), myocardial (B-type natriuretic peptide [BNP]35 pg/mL) and renal dysfunction (estimated glomerular filtration rate [eGFR]60 mL/min/1.73 m(2)), and dyslipidemia to refine the healthy cohort. The 99th percentile URLs were independently determined by the non-parametric and robust methods.The use of biomarker selection criteria resulted in a decrea…

AdultMalemedicine.medical_specialtyPercentileSensitivity and SpecificityCohort Studieschemistry.chemical_compoundReference ValuesInternal medicineHumansMedicineMyocardial infarctionUnivariate analysisbusiness.industryPatient SelectionTroponin IMiddle Agedmedicine.diseaseConfidence intervalEuropeEndocrinologychemistryCohortFemaleGlycated hemoglobinCardiology and Cardiovascular MedicinebusinessBody mass indexBiomarkersDyslipidemiaInternational Journal of Cardiology
researchProduct

Percutaneous transluminal coronary rotary ablation with Rotablator (European experience)

1992

This study reports the results from 3 European centers using rotary ablation with Rotablator, a device that is inserted into the coronary artery and removes atheroma by grinding it into millions of tiny fragments. Rotary ablation was performed in 129 patients. Primary success (reduction in percent luminal narrowing greater than 20%, residual stenosis less than 50%, without complications) was achieved by rotary angioplasty alone in 73 patients (57%). An additional 38 patients (29%) had successful adjunctive balloon angioplasty. Thus primary success was achieved in 111 patients (86%) at the end of the procedure. Acute occlusion occurred in 10 patients (7.7%). Recanalization was achieved by ba…

AdultMalemedicine.medical_specialtyPercutaneousmedicine.medical_treatmentCoronary DiseaseCoronary AngiographyBalloonAtherectomyRestenosisRecurrenceAngioplastyInternal medicinemedicineHumansMyocardial infarctionAngioplasty Balloon CoronaryAgedmedicine.diagnostic_testbusiness.industryMiddle Agedmedicine.diseaseAblationSurgeryEuropeAngiographyCardiologyFemaleRadiologyCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe American Journal of Cardiology
researchProduct